Graph showing the Human CD48, hFc Tag ELISA with a 0.1 µg concentration of Human 2B4 His Tag per well. The x-axis represents the log concentration of Human CD48, hFc Tag (µg/ml), and the y-axis shows the mean absorbance (OD450). The curve demonstrates a dose-dependent increase in absorbance.
Human CD48/SLAMF2 Protein (SLA-HM2MF)
Human CD48/SLAMF2 Protein (SLA-HM2MF)
  • Express System: HEK293
  • Product Tag: C-hFc (IgG1)
  • Purity: > 95% as determined by Bis-Tris PAGE;> 95% as determined by HPLC
  • Activity: Immobilized Human 2B4, His Tag at 1ug/ml (100ul/well) on the plate. Dose response curve for Human CD48, hFc Tag with the EC50 of 0.34ug/ml determined by ELISA.
  • Amino Acid Range: Gln27-Ser220
Catalog #SLA-HM2MF
Regular price $280.50
/
Size
image image

Order by 4pm ET for delivery on:

Human CD48/SLAMF2 Protein (SLA-HM2MF) Summary

Product Description

Recombinant Human CD48/SLAMF2 Protein is expressed from HEK293 with hFc (IgG1) tag at the C-Terminus.It contains Gln27-Ser220.

Product Background

CD48, also known as BLAST-1, BCM-1, and SLAMF2, is a 65 kDa GPI-linked protein in the CD2 family of immunoglobulin superfamily molecules.CD2 and 2B4 (CD244) are known ligands for CD48. CD48 protein is expressed on most lineage-committed hematopoietic cells but not on hematopoietic stem cells or multipotent hematopoietic progenitors.

Product Category

Recombinant Protein / Antibody discovery / Immune checkpoint proteins | ADC targets

Human CD48/SLAMF2 Protein (SLA-HM2MF) Specifications/Details

Protein
CD48/SLAMF2
Synonyms
CD48 molecule; CD48; SLAMF2; BCM1; BLAST; BLAST1; BLAST1TCT.1;- mCD48; MEM-102; TCT.1
Accession
Species
Human
Biotinylated
no
Amino Acid Range
Gln27-Ser220
Molecular Weight
The protein has a predicted MW of 48.9 kDa. Due to glycosylation, the protein migrates to 62-72 kDa based on Bis-Tris PAGE result.
Activity
Immobilized Human 2B4, His Tag at 1ug/ml (100ul/well) on the plate. Dose response curve for Human CD48, hFc Tag with the EC50 of 0.34ug/ml determined by ELISA.
Product Tag
C-hFc (IgG1)

Fluorophore

Unconjugated
Expression System
HEK293
Purity
> 95% as determined by Bis-Tris PAGE;> 95% as determined by HPLC
Endotoxin
Less than 1 EU per ug by the LAL method.

Shipping, Reconstitution, & Storage

Form
Lyophilized
Shipping
Shipped at ambient temperature.
Formulation
Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution
Dissolve the lyophilized protein in distilled water. It is recommended to resuspend at 0.5 mg/mL if the lyophilized powder is 100 ug or less, at 1mg/ml for 500ug or 1mg lyophilized powder. Do not mix by vortex or vigorous shaking.
Stability And Storage
-20 to -80°C for 12 months as supplied from date of receipt.;-80°C for 3 months after reconstitution.;Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.

Validation Images

Immobilized Human 2B4, His Tag at 1ug/ml (100ul/well) on the plate. Dose response curve for Human CD48, hFc Tag with the EC50 of 0.34ug/ml determined by ELISA. Immobilized Human 2B4, His Tag at 1ug/ml (100ul/well) on the plate. Dose response curve for Human CD48, hFc Tag with the EC50 of 0.34ug/ml determined by ELISA.
Human CD48 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. Human CD48 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
Loaded Human CD48, hFc Tag on ProA-Biosensor can bind Human 2B4, His Tag with an affinity constant of 0.51 µM as determined in BLI assay . Loaded Human CD48, hFc Tag on ProA-Biosensor can bind Human 2B4, His Tag with an affinity constant of 0.51 µM as determined in BLI assay .
The purity of Human CD48 is greater than 95% as determined by SEC-HPLC. The purity of Human CD48 is greater than 95% as determined by SEC-HPLC.
Other Available Proteins:
Finding available proteins...
Have more questions?

Check out our Frequently Asked Questions page for more details about product specifications, ordering, and shipments.

Recommended Products

Loading...
Recently viewed